Virica Biotech
Virica Biotech19About
What does Virica Biotech do?
Virica Biotech is a cell enhancer company focused on developing and commercializing Viral Sensitizers (VSE™). These proprietary technologies are designed to improve the efficiency and yield of viral vector manufacturing, a critical component in the development of gene therapies and other advanced biologics. The company collaborates with industry partners to optimize its VSE™ formulations for specific applications.
What is Virica Biotech's revenue?
StartupHub estimates Virica Biotech's annual revenue at $2.9M (range $1.9M to $12.8M, 69% confidence), based on comparable companies in the sector.
Where is Virica Biotech headquartered?
Virica Biotech is headquartered in Ottawa, Ontario, Canada.
What industry does Virica Biotech operate in?
Virica Biotech operates in Biotechnology, Pharmaceuticals, Life Sciences.
How many employees does Virica Biotech have?
Virica Biotech has approximately 32 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.